Expression of trefoil peptides in the subtypes of intestinal metaplasia

Peptides

Volumn 25, Issue 5, 2004, Pages 779-783

  Kim, Byung Wook ^a   Kim, Kyoung Mee ^a   Lee, Bo In ^a   Maeng, Lee So ^a   Choi, Hwang ^a   Cho, Se Hyun ^a   Chae, Hiun Suk ^a   Kim, Jae Kwang ^a   Choi, Kyu Yong ^a   Chung, In Sik ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Immunohistochemistry; Metaplasia; Stomach; Trefoil peptide

Indexed keywords

ALCIAN BLUE; DIAMINE; IRON; TREFOIL PEPTIDE;

ARTICLE; CELL TYPE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; DISEASE COURSE; DYSPEPSIA; ENDOSCOPIC BIOPSY; GOBLET CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STAINING; STOMACH;

DYSPEPSIA; HUMANS; IMMUNOHISTOCHEMISTRY; MUCINS; MUSCLE PROTEINS; NEOPLASM STAGING; PEPTIDES; PROTEINS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

LOTUS;

EID: 2642535868     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.12.021     Document Type: Article

References (19)

1. Craanen M.E., Blok P., Dekker W., Ferwerda J., Tytgat G.N.J. Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa. Dig. Dis. Sci. 36:1991;1529-1536
2. Filipe MI, Jass JR. Intestinal metaplasia subtypes and cancer risk. In: Filipe MI, Jass JR, editors. Gastric carcinoma. London: Churchill Livingstone; 1986. p. 87-115.
3. Filipe MI, Lake BD. Appendix 3. In: Filipe MI, Lake BD, editors. Histochemistry in pathology. 2nd ed. London: Churchill Livingstone; 1990. p. 449-53.
4. Filipe MI. Gastrointestinal carcinoma and precursor lesions. In: Filipe MI, Lake BD, editors. Histochemistry in pathology. 2nd ed. London: Churchill Livingstone; 1990. p. 175-98.
5. Filipe MI. Borderline lesions of the gastric epithelium: new indicators of gastric risk and clinical implications. In: Fenoglio-Preiser CM, Wolff M, Rilke F, editors. Progress in surgical pathology. Philadelphia: Field & Wood Medical Publishers; 1992. p. 269-90.
6. Fujimoto J., Yasui W., Tahara H., Tahara E., Kudo Y., Yokozaki H., et al. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis. Cancer Lett. 149:2000;125-134
7. Hanby A.M., Poulsom R., Singh S., Elia G., Jeffery R.E., Wright N.A. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology. 105:1993;1110-1116
8. Hu G.Y., Yu B.P., Dong W.G., Li M.Q., Yu J.P., Luo H.S., et al. Expression of TFF2 and Helicobacter pylori infection in carcinogenesis of gastric mucosa. World J. Gastroenterol. 9:2003;910-914
9. Kim H.S., Lee Y.C., Lee H.W., Yoo H.M., Lee C.G., Kim J.M., et al. Seroepidemiologic study of Helicobacter pylori in Korea. Kor. J. Gastroenterol. 33:1999;170-182
10. Leung W.K., Sung J.J. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment. Pharmacol. Ther. 16:2002;1209-1216
11. Machado J.C., Nogueira A.M., Carneiro F., Reis C.A., Sobrinho-Simoes M. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J. Pathol. 190:2000;437-443
12. Ministry of Health and Welfare, Republic of Korea. Annual Report on National Cancer Registry; 2001.
13. Nogueira A.M., Machado J.C., Carneiro F., Reis C.A., Gott P., Sobrinho-Simoes M. Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation. J. Pathol. 187:1999;541-548
14. Park W.S., Oh R.R., Park J.Y., Lee J.H., Shin M.S., Kim H.S., et al. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology. 119:2000;691-698
15. Reis C.A., David L., Correa P., Carneiro F., de Bolos C., Garcia E., et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 59:1999;1003-1007
16. Rokkas T., Filipe M.I., Sladen G.E. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut. 32:1991;1110-1113
17. Sands B.E., Podolsky D.K. The trefoil peptide family. Annu. Rev. Physiol. 58:1996;253-273
18. Silva S., Filipe M.I. Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects: a comparative analysis of biopsy and gastrectomy material. Hum. Pathol. 17:1986;988-995
19. Taupin D., Pedersen J., Familari M., Cook G., Yeomans N., Giraud A.S. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium. Lab. Invest. 81:2001;397-408